TransMedics appoints new CCO and new General Counsel in leadership transition

TransMedics Group, Inc.

Giovanni Cecere appointed Chief Commercial Officer effective Feb 2, 2026, succeeding Tamer Khayal who becomes SVP International.
Matthew Forsyth appointed SVP, General Counsel & Corporate Secretary effective March 9, 2026, succeeding Anil Ranganath.
Anil Ranganath transitions to non-executive employee until June 7, 2026, then consultant through Sept 7, 2026; retains base salary and equity vesting.
Ranganath eligible for severance of 0.75x highest salary+bonus, COBRA for 9 months, and pro-rated 2026 bonus subject to release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.